Crinetics Pharmaceuticals
Novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers. Learn more
Launch date
Employees
Market cap
€3.9b
Enterprise valuation
€3.2b (Public information from Sep 2024)
Share price
$53.88 CRNX
San Diego California (HQ)
Authorizing premium user...